Zobrazeno 1 - 10
of 11
pro vyhledávání: '"K L Belonga"'
Autor:
David A. Kloosterman, L V Goodman, J.D Petke, G Vogeli, Vincent P. Marshall, B Mao, R. A. Poorman, D.J Waldon, S.A Mizsak, M. A. Mitchell, P S Kaytes, E.J Jacobsen, K L Belonga, G. L. Petzold, E.A Powers, Terrence A. Scahill, J.A Gates, S.R Ledbetter, Brian J. Stockman
Publikováno v:
Scopus-Elsevier
Unregulated or overexpressed matrix metalloproteinases (MMPs), including stromelysin, collagenase, and gelatinase. have been implicated in several pathological conditions including arthritis and cancer. Small-molecule MMP inhibitors may have therapeu
Autor:
Wha Bin Im, Eric Jon Jacobsen, K. L. Belonga, Vimala H. Sethy, Donald B. Carter, J. D. Petke, L. S. Stelzer, Philip F. VonVoigtlander, Andrew H. Tang
Publikováno v:
Journal of Medicinal Chemistry. 39:3820-3836
A series of imidazo[1,5-alpha]quinoxalin-4-ones and imidazo[1,5-alpha]quinoxaline ureas containing substituted phenyl groups at the 3-position was developed. Compounds within the imidazo[1,5-alpha]quinoxaline urea series had high affinity for the GAB
Autor:
J. D. Petke, L. S. Stelzer, Donald B. Carter, Philip F. VonVoigtlander, Tenbrink Ruth E, H. K. Im, Vimala H. Sethy, Eric Jon Jacobsen, Wha Bin Im, Andrew H. Tang, K. L. Belonga
Publikováno v:
Journal of Medicinal Chemistry. 39:158-175
A series of imidazo[1,5-a]quinoxaline amides, carbamates, and ureas which have high affinity for the gamma-aminobutyric acid A/benzodiazepine receptor complex was developed. Compounds within this class have varying efficacies ranging from antagonists
Publikováno v:
The Journal of Organic Chemistry. 60:4177-4183
Publikováno v:
ChemInform. 26
Autor:
G. E. Padbury, P. G. Larson, C. S. Aaron, L. S. Banitt, K. L. Linseman, J. K. Mayo, J. E. Chin, P. A. Yonkers, Heidi M. Scherch, E. D. Hall, Stephen A. Mizsak, K. L. Belonga, Gordon L. Bundy, J. M. Lin, F. F. Sun, J. M. Tustin, I. M. Richards, Donald E. Ayer, John R. Palmer
Publikováno v:
ChemInform. 27
Autor:
Eric Jon Jacobsen, K. L. Belonga, VanDoornik Fj, David J. Houser, Braughler Jm, Edward D. Hall, Donald E. Ayer
Publikováno v:
Journal of Medicinal Chemistry. 35:4464-4472
A series of 2-(aminomethyl)chromans was developed as potent inhibitors of iron-dependent lipid peroxidation. Compounds within this class are extremely effective at inhibiting lipid peroxidation with IC50's as low as 0.2 microM. Selected members were
Autor:
E D, Hall, P K, Andrus, S L, Smith, J A, Oostveen, H M, Scherch, B S, Lutzke, T J, Raub, G A, Sawada, J R, Palmer, L S, Banitt, J S, Tustin, K L, Belonga, D E, Ayer, G L, Bundy
Publikováno v:
Acta neurochirurgica. Supplement. 66
The 21-aminosteroid (lazaroid) tirilazad mesylate has been demonstrated to be a potent inhibitor of lipid peroxidation and to reduce traumatic and ischemic damage in a number of experimental models. Currently, tirilazad is being actively investigated
Autor:
Gordon L. Bundy, Geri A. Sawada, Paula K. Andrus, Sarah L. Smith, J. S. Tustin, John R. Palmer, Edward D. Hall, Donald E. Ayer, Thomas J. Raub, Barry S. Lutzke, Jo A. Oostveen, Heidi M. Scherch, K. L. Belonga, L. S. Banitt
Publikováno v:
Mechanisms of Secondary Brain Damage in Cerebral Ischemia and Trauma ISBN: 9783709194676
The 21-aminosteroid (lazaroid) tirilazad mesylate has been demonstrated to be a potent inhibitor of lipid peroxidation and to reduce traumatic and ischemic damage in a number of experimental models. Currently, tirilazad is being actively investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8124d77933406848f8de36a79d00aa7
https://doi.org/10.1007/978-3-7091-9465-2_19
https://doi.org/10.1007/978-3-7091-9465-2_19
Autor:
J. E. Chin, Donald E. Ayer, Gordon L. Bundy, K. L. Belonga, Edward D. Hall, L. S. Banitt, K. L. Linseman, S A Mizsak, J. M. Tustin, John R. Palmer
Publikováno v:
Journal of medicinal chemistry. 38(21)